What You Should Know:
– Medidata, a Dassault Systèmes company and Parexel, a global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health extends their 15-year global strategic partnership. This extension includes gaining access to Medidata’s continued innovations in clinical trial technology solutions with its unified platform, support of decentralized clinical trials (DCTs), the myMedidata patient portal, Sensor Cloud, and Medidata’s proprietary Patient Centricity by Design program.
– Parexel contributed to the growth of myMedidata, Medidata’s patient portal, by participating in the Early Adopter Program, providing feedback and helping the portal meet the needs of patients, sites and sponsors. With myMedidata, patients can virtually access all of their clinical trial needs through one web-based portal, removing the need for provisioned devices and improving clinical trial experiences. Parexel is now using most of the Medidata Clinical Cloud platform, including eCOA (clinical outcome assessment), RTSM (randomization and trial supply management), Imaging, and now Sensor Cloud technology.
